SCHEMBL9506671

SCHEMBL9506671

CCCCCCCCCC(=O)NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.81
ITGB3 P05106 2/20 0.65
ITGA2B P08514 2/20 0.65
PSMB5 P28074 2/20 0.64
HDAC3 O15379 1/20 0.60
HDAC4 P56524 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC7 Q8WUI4 1/20 0.60
HDAC2 Q92769 1/20 0.60
HDAC10 Q969S8 1/20 0.60
HDAC11 Q96DB2 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
HDAC9 Q9UKV0 1/20 0.60
HDAC5 Q9UQL6 1/20 0.60
NOD1 Q9Y239 1/20 0.58
EPHX2 P34913 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4066786 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL9716823 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL1815009 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL1815011 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL9666114 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL22494096 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL22494095 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL21998924 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL22494097 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3
SCHEMBL15285319 1.00 FAAH (0.81) FAAHITGB3ITGA2BPSMB5HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238917-A Drug delivery, storage stability TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) 1993-08-24 US claimed
EP-0418642-B1 HIGH-ABSORBABLE TRANSVAGINAL PREPARATION CONTAINING BIOLOGICALLY ACTIVE PEPTIDES TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) 1993-06-09 EP claimed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP claimed
EP-0418642-A1 High-absorbable transvaginal preparation containing biologically active peptides TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) 1991-03-27 EP claimed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO claimed
WO-2019005617-A1 ANTIBACTERIAL LIPOPEPTIDES AND METHODS FOR THEIR PREPARATION AND USE Ramapo Pharmaceuticals, Inc. (US) 2019-01-03 WO disclosed
US-5238917-A Drug delivery, storage stability TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) 1993-08-24 US disclosed
EP-0418642-B1 HIGH-ABSORBABLE TRANSVAGINAL PREPARATION CONTAINING BIOLOGICALLY ACTIVE PEPTIDES TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) 1993-06-09 EP disclosed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP disclosed
EP-0178911-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1992-01-22 EP disclosed
EP-0418642-A1 High-absorbable transvaginal preparation containing biologically active peptides TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) 1991-03-27 EP disclosed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO disclosed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US disclosed
EP-0178911-A2 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1986-04-23 EP disclosed